Skip to content

DR. EECKELAERT

Active Private limited companyfounded 2003active for 22 yearsVan Colenstraat 3, 2530 BoechoutKBO/BCE: BE 0862.377.708

Lifetime

19 annual accounts with figures on one time axis, 21 filings since 2005
peak of €235,294 in 2014
€89,346▲ 95.5%
peak of €123,927 in 2014
€40,569▲ 297%
peak of €952,127 in 2023
€543,902▲ 8.1%
€28,298▼ 68.0%
Board1 name since 2013
1 director
Documentsfilings and deeds
15-01-202616 days before the deadline
2025micro format
Gross margin from €45,700 to €89,346Result from €10,206 to €40,569Debts from €88,299 to €28,298Cash from €23,841 to €3,813

Key points

from the 2025 annual accounts

Equity

€543,902 ▲ 8.1%

DR. EECKELAERT has made a profit in every financial year since 2007.

Liquidity

1.67 was 0.48 in 2024

Short-term debts fell from €79,583 to €23,351.

Filings

21 annual accounts since 2005
deadline20052010201520202025

The last five annual accounts were filed 16 to 54 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as DR. EECKELAERT has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for DR. EECKELAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • deed of 14-03-2014
Board & ownership

Recent changes

Capital decrease of €6,600 to €0 After the decrease, the capital stands at €0 · “Het ter beschikking stellen van alle nuttige of nodige middelen,materialen,infrastructuur,ruimten en/of…” (deed in Dutch) · General meeting of 14-03-2023 · Gazette deed
Capital decrease of €352,260 to €19,000 The capital fell from €371,260 to €19,000, cancelling 1,854 shares · General meeting of 28-06-2018 · Gazette deed
Capital increase of €352,260 to €371,260 After the increase, the capital stands at €371,260, with 1,854 new shares · Contribution by · General meeting of 14-02-2014 · Gazette deed
reappointed as manager General meeting of 22-12-2013 · Gazette deed
All 32 events

Official details

Source: KBO
Status
Active since 23-12-2003Normal situation
Activity
“Het ter beschikking stellen van alle nuttige of nodige middelen,materialen,infrastructuur,ruimten en/of lokalen dienstig voor…” (deed in Dutch)From the articles, 6 activities1 activity on the establishment unit
Establishment unit
2.303.478.5962530 Boechout, since 23-12-2003
Financial year end
30 June
Peppol
Reachable
Company details

Annual accounts to 30-06-2025

≈ €260,000estimated
€572,200▼ 3.3%
Filing
Filed on 15-01-2026, 16 days before the end of the filing period
Financials

Insights on DR. EECKELAERT

DR. EECKELAERT files the micro format. That format states no turnover. The gross margin fell from €96,604 in 2007 to €89,346 in 2025.

The balance sheet grew most from 2012 to 2014 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. EECKELAERT

What is the company number of DR. EECKELAERT?
The company number of DR. EECKELAERT is 0862.377.708. The VAT number is the same number with BE in front: BE 0862.377.708.
Where is DR. EECKELAERT based?
The registered office is at Van Colenstraat 3, 2530 Boechout.Company details
What is the legal form of DR. EECKELAERT?
DR. EECKELAERT is a private limited company (BV).
When was DR. EECKELAERT founded?
DR. EECKELAERT was founded on 23-12-2003.
Is DR. EECKELAERT still active?
Yes, DR. EECKELAERT is an active enterprise in the KBO register.
What is the turnover of DR. EECKELAERT?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €89,346 and 2,982 comparable companies of the same size. It probably lies between €170,000 and €460,000. It is a rough estimate.Financials
Is DR. EECKELAERT profitable?
In financial year 2025, DR. EECKELAERT made a profit of €40,569.
Where can I find the annual accounts of DR. EECKELAERT?
DR. EECKELAERT filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. EECKELAERT due?
DR. EECKELAERT must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.